 | • レポートコード：QYR9N7087 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、うつ病性障害のグローバル市場について調査・分析したレポートで、種類別（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン - ノルエピネフリン再取り込み阻害薬、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬および再取り込み阻害薬、その他）、用途別（病院、外来手術センター、診断センター、在宅ケアの設定、介護センター、その他 、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・うつ病性障害の世界市場規模 ・主要企業別市場シェア ・うつ病性障害の世界市場規模：種類別（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン - ノルエピネフリン再取り込み阻害薬、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬および再取り込み阻害薬、その他） ・うつ病性障害の世界市場規模：用途別（病院、外来手術センター、診断センター、在宅ケアの設定、介護センター、その他 、） ・うつ病性障害のアメリカ市場規模（種類別、用途別） ・うつ病性障害のヨーロッパ市場規模（種類別、用途別） ・うつ病性障害の中国市場規模（種類別、用途別） ・うつ病性障害の日本市場規模（種類別、用途別） ・うつ病性障害の東南アジア市場規模（種類別、用途別） ・うつ病性障害のインド市場規模（種類別、用途別） ・うつ病性障害の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・うつ病性障害の世界市場予測（2019年-2025年） ・うつ病性障害の地域別市場予測（2019年-2025年） ... |
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
In 2018, the global Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Depressive Disorder development in United States, Europe and China.
The key players covered in this study
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
Takeda Pharmaceutical
Market segment by Type, the product can be split into
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Long Term Care Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Depressive Disorder status, future forecast, growth opportunity, key market and key players.
To present the Depressive Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Depressive Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Depressive Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Tricyclic Antidepressants
1.4.3 Selective Serotonin Reuptake Inhibitors
1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Serotonin Antagonist And Reuptake Inhibitors
1.4.7 Others
1.5 Market by Application
1.5.1 Global Depressive Disorder Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.5.5 Homecare Settings
1.5.6 Long Term Care Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Depressive Disorder Market Size
2.2 Depressive Disorder Growth Trends by Regions
2.2.1 Depressive Disorder Market Size by Regions (2014-2025)
2.2.2 Depressive Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Depressive Disorder Market Size by Manufacturers
3.1.1 Global Depressive Disorder Revenue by Manufacturers (2014-2019)
3.1.2 Global Depressive Disorder Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Depressive Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Depressive Disorder Key Players Head office and Area Served
3.3 Key Players Depressive Disorder Product/Solution/Service
3.4 Date of Enter into Depressive Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Depressive Disorder Market Size by Type (2014-2019)
4.2 Global Depressive Disorder Market Size by Application (2014-2019)
5 United States
5.1 United States Depressive Disorder Market Size (2014-2019)
5.2 Depressive Disorder Key Players in United States
5.3 United States Depressive Disorder Market Size by Type
5.4 United States Depressive Disorder Market Size by Application
6 Europe
6.1 Europe Depressive Disorder Market Size (2014-2019)
6.2 Depressive Disorder Key Players in Europe
6.3 Europe Depressive Disorder Market Size by Type
6.4 Europe Depressive Disorder Market Size by Application
7 China
7.1 China Depressive Disorder Market Size (2014-2019)
7.2 Depressive Disorder Key Players in China
7.3 China Depressive Disorder Market Size by Type
7.4 China Depressive Disorder Market Size by Application
8 Japan
8.1 Japan Depressive Disorder Market Size (2014-2019)
8.2 Depressive Disorder Key Players in Japan
8.3 Japan Depressive Disorder Market Size by Type
8.4 Japan Depressive Disorder Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Depressive Disorder Market Size (2014-2019)
9.2 Depressive Disorder Key Players in Southeast Asia
9.3 Southeast Asia Depressive Disorder Market Size by Type
9.4 Southeast Asia Depressive Disorder Market Size by Application
10 India
10.1 India Depressive Disorder Market Size (2014-2019)
10.2 Depressive Disorder Key Players in India
10.3 India Depressive Disorder Market Size by Type
10.4 India Depressive Disorder Market Size by Application
11 Central & South America
11.1 Central & South America Depressive Disorder Market Size (2014-2019)
11.2 Depressive Disorder Key Players in Central & South America
11.3 Central & South America Depressive Disorder Market Size by Type
11.4 Central & South America Depressive Disorder Market Size by Application
12 International Players Profiles
12.1 Alkermes
12.1.1 Alkermes Company Details
12.1.2 Company Description and Business Overview
12.1.3 Depressive Disorder Introduction
12.1.4 Alkermes Revenue in Depressive Disorder Business (2014-2019)
12.1.5 Alkermes Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Depressive Disorder Introduction
12.2.4 Allergan Revenue in Depressive Disorder Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Bristol Myers Squibb
12.3.1 Bristol Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Depressive Disorder Introduction
12.3.4 Bristol Myers Squibb Revenue in Depressive Disorder Business (2014-2019)
12.3.5 Bristol Myers Squibb Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Depressive Disorder Introduction
12.4.4 Eli Lilly Revenue in Depressive Disorder Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Glaxosmithkline
12.5.1 Glaxosmithkline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Depressive Disorder Introduction
12.5.4 Glaxosmithkline Revenue in Depressive Disorder Business (2014-2019)
12.5.5 Glaxosmithkline Recent Development
12.6 H. Lundbeck
12.6.1 H. Lundbeck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Depressive Disorder Introduction
12.6.4 H. Lundbeck Revenue in Depressive Disorder Business (2014-2019)
12.6.5 H. Lundbeck Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Depressive Disorder Introduction
12.7.4 Merck Revenue in Depressive Disorder Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Depressive Disorder Introduction
12.8.4 Pfizer Revenue in Depressive Disorder Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Depressive Disorder Introduction
12.9.4 Teva Pharmaceutical Revenue in Depressive Disorder Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development
12.10 Takeda Pharmaceutical
12.10.1 Takeda Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Depressive Disorder Introduction
12.10.4 Takeda Pharmaceutical Revenue in Depressive Disorder Business (2014-2019)
12.10.5 Takeda Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Depressive Disorder Key Market Segments
Table Key Players Depressive Disorder Covered
Table Global Depressive Disorder Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Depressive Disorder Market Size Market Share by Type 2014-2025
Figure Tricyclic Antidepressants Figures
Table Key Players of Tricyclic Antidepressants
Figure Selective Serotonin Reuptake Inhibitors Figures
Table Key Players of Selective Serotonin Reuptake Inhibitors
Figure Serotonin-Norepinephrine Reuptake Inhibitors Figures
Table Key Players of Serotonin-Norepinephrine Reuptake Inhibitors
Figure Monoamine Oxidase Inhibitors Figures
Table Key Players of Monoamine Oxidase Inhibitors
Figure Serotonin Antagonist And Reuptake Inhibitors Figures
Table Key Players of Serotonin Antagonist And Reuptake Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Depressive Disorder Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Homecare Settings Case Studies
Figure Long Term Care Centers Case Studies
Figure Depressive Disorder Report Years Considered
Table Global Depressive Disorder Market Size 2014-2025 (Million US$)
Figure Global Depressive Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Depressive Disorder Market Size by Regions 2014-2025 (Million US$)
Table Global Depressive Disorder Market Size by Regions 2014-2019 (Million US$)
Table Global Depressive Disorder Market Share by Regions 2014-2019
Figure Global Depressive Disorder Market Share by Regions 2014-2019
Figure Global Depressive Disorder Market Share by Regions 2019
Table Market Top Trends
Table Global Depressive Disorder Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Depressive Disorder Market Share by Manufacturers (2014-2019)
Figure Global Depressive Disorder Market Share by Manufacturers in 2018
Table Global Depressive Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Depressive Disorder Product/Solution/Service
Table Date of Enter into Depressive Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Global Depressive Disorder Market Size Share by Type (2014-2019)
Figure Global Depressive Disorder Market Size Market Share by Type (2014-2019)
Table Global Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Global Depressive Disorder Market Size Share by Application (2014-2019)
Figure Global Depressive Disorder Market Size Market Share by Application (2014-2019)
Figure Global Depressive Disorder Revenue Market Share by Application in 2018
Figure United States Depressive Disorder Market Size 2014-2019 (Million US$)
Table United States Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table United States Key Players Depressive Disorder Market Share (2018-2019)
Table United States Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table United States Depressive Disorder Market Share by Type (2014-2019)
Table United States Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table United States Depressive Disorder Market Share by Application (2014-2019)
Figure Europe Depressive Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players Depressive Disorder Market Share (2018-2019)
Table Europe Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Europe Depressive Disorder Market Share by Type (2014-2019)
Table Europe Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Europe Depressive Disorder Market Share by Application (2014-2019)
Figure China Depressive Disorder Market Size 2014-2019 (Million US$)
Table China Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table China Key Players Depressive Disorder Market Share (2018-2019)
Table China Depressive Disorder Market Size by Type (2014-20189) (Million US$)
Table China Depressive Disorder Market Share by Type (2014-2019)
Table China Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table China Depressive Disorder Market Share by Application (2014-2019)
Figure Japan Depressive Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players Depressive Disorder Market Share (2018-2019)
Table Japan Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Japan Depressive Disorder Market Share by Type (2014-2019)
Table Japan Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Japan Depressive Disorder Market Share by Application (2014-2019)
Figure Southeast Asia Depressive Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Depressive Disorder Market Share (2018-2019)
Table Southeast Asia Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Depressive Disorder Market Share by Type (2014-2019)
Table Southeast Asia Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Depressive Disorder Market Share by Application (2014-2019)
Figure India Depressive Disorder Market Size 2014-2019 (Million US$)
Table India Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table India Key Players Depressive Disorder Market Share (2018-2019)
Table India Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table India Depressive Disorder Market Share by Type (2014-2019)
Table India Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table India Depressive Disorder Market Share by Application (2014-2019)
Figure Central & South America Depressive Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Depressive Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Depressive Disorder Market Share (2018-2019)
Table Central & South America Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Central & South America Depressive Disorder Market Share by Type (2014-2019)
Table Central & South America Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Central & South America Depressive Disorder Market Share by Application (2014-2019)
Table Alkermes Company Details
Table Alkermes Revenue in Depressive Disorder Business (2014-2019) (Million US$)
Figure Alkermes Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Alkermes Recent Development
Table Allergan Company Details
Table Allergan Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Allergan Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Eli Lilly Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Glaxosmithkline Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Glaxosmithkline Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table H. Lundbeck Recent Development
Table Merck Company Details
Table Merck Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Pfizer Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Depressive Disorder Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Depressive Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global Depressive Disorder Market Size Share by Regions (2019-2025)
Figure Global Depressive Disorder Market Size Share by Regions in 2025
Figure United States Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global Depressive Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global Depressive Disorder Market Size by Product (2019-2025)
Figure Global Depressive Disorder Market Size by Product in 2025
Table Global Depressive Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global Depressive Disorder Market Size by Application (2019-2025)
Figure Global Depressive Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の産後うつ病治療薬市場：市場規模・現状・予測 Postpartum depression is a prevalent disorder affecting many women of reproductive age.Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depres…- 世界のCox-2阻害剤市場：市場規模・現状・予測 Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.In 2018, the global Cox-2 Inhibitors market size was …
- 世界の大鬱病性障害市場：市場規模・現状・予測 Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …
- 世界の大うつ病性障害市場：市場規模・現状・予測 Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …
- 世界のシグナル伝達阻害剤市場：市場規模・現状・予測 Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibito…